Private Equity Firm Profile
OrbiMed Advisors’ most common sectors for investment arelife science (75%) and medical products (25%) . The Firm’s most common investment types include growth capital (50%) and venture (50%). In total, OrbiMed Advisors has invested in 2 US states and 2 different countries.
The Firm’s most common exit type is ipo (50%). OrbiMed Advisors’ largest (disclosed) exit occurred in 2018 when it sold GENEWIZ for $450M.
Join Mergr to view OrbiMed Advisors’ full profile and discover more large private equity firm investors just like it.
M&A Summary
-
M&A Total Activity8
- M&A Buy Activity4
- M&A Sell Activity4
- Total Sectors Invested 2
- Total Countries Invested 2
- M&A Buy/Sell Connections 6
- M&A Advisors 1
Unlimited Searches
